Mindfulness-based Virtual Reality Intervention
Through virtual reality technology and mindfulness therapy, we can intervene the patients with Hematologic Neoplasms during chemotherapy, hoping to improve their symptoms and self-efficacy.
|Condition or Disease||Intervention/Treatment||Phase|
In recent years, the intervention method of giving mindfulness has achieved good results in the management of symptoms related to cancer patients, but the compliance of patients with conventional mindfulness intervention is low. The virtual reality intervention based on mindfulness can effectively mobilize the enthusiasm of patients to participate in research and the compliance of mindfulness training. We aim to combine virtual reality with mindfulness intervention to intervene patients with hematologic neoplasms during chemotherapy, To improve their symptoms.
Arms and Interventions
|Experimental: Virtual reality+Mindfulness
Intervention method combining virtual reality technology and mindfulness therapy, twice a week, lasting for 7 weeks
Device: virtual reality device
mindfulness combined with virtual reality
|No Intervention: Mindfulness
Intervention method of mindfulness therapy, twice a week, lasting for 7 weeks
Primary Outcome Measures
- MDASI-C [up to 7 weeks]
Symptom burden was assessed using the Chinese version of the M. D. Anderson Symptom Inventory (MDASI-C),39 which is a self-report scale consisting of two domains. The first domain is named "core symptom severity items" and has 13 symptoms. Each symptom is rated on an 11-point scale (0-10) to indicate the presence and severity of the symptom, with 0 indicating "not present" and 10 indicating "as bad as you can imagine." Each symptom is rated based on the severity of the symptom, at its worst, in the last 24 h. The second domain is named "six symptoms interference items" and includes ratings of how much symptoms interfered with different aspects of the survivor's life in the last 24 h. The interference items are also rated on a scale of 0-10, with 0 indicating "did not interfere" and 10 indicating "interfered completely." A score of 0-3 indicated a mild level, 4-6 indicated a moderate level, and 7-10 indicated a severe level of symptom severity or interference.
- Hospital Anxiety and Depression Scale (HADS) [up to 7 weeks]
The hospital anxiety and depression scale The HADS was compiled by Zigmond AS Which was used to detect states of depression and anxiety in the setting of an hospital medical outpatient clinic . It is a 14-question instrument, with each question being scored between 0 (no impairment) and 3 (severe impairment), with a maximum score of 21 for anxiety or depression.
Secondary Outcome Measures
- the self-management efficacy scale (C-SUPPH) [up to 7 weeks]
the self-management efficacy scale (C-SUPPH)，The C-SUPPH scale consisted of 28 items in three dimensions: self-decompression, self-decision-making, and positive attitude, with each item scoring 1-5 points and a total score of 28-140 points. The higher the total score is, the higher the self-efficacy is.
Clinical diagnosis of Hematologic Neoplasms(leukemia, lymphoma or multiple myeloma) and receiving chemotherapy
Hospitalized for more than 4 weeks
Have normal communication ability, clear consciousness, and willing to participate in this study
People are cognitive dysfunction and audio-visual dysfunction
Have mental problems or have reported mental disorders
Contacts and Locations
|1||the First Affiliated Hospital of Nanjing Medical University||Nanjing||Jiangsu||China|
Sponsors and Collaborators
- Nanjing University of Traditional Chinese Medicine
- Study Director: yuxi Zhang, The First Affiliated Hospital with Nanjing Medical University
Study Documents (Full-Text)None provided.